Samenvatting
Door middel van een gestructureerde medicatie-analyse door klinisch geriater en ziekenhuisapotheker-klinisch farmacoloog zijn (potentiële) geneesmiddelgerelateerde problemen in kaart gebracht. Patiënten die werden opgenomen op de afdeling geriatrie en waar de klinisch geriater en/of de ziekenhuisapotheker problemen zagen of voorzagen werden beoordeeld volgens een vast model. De voorgestelde interventies werden plenair besproken en de uitgevoerde (of overgenomen) interventies werden vervolgd.
In een periode van 30 maanden werden de medicatiegegevens van 184 patiënten aan een medicatie-analyse onderworpen. Van de voorgestelde interventies door de ziekenhuisapotheker werd 65% overgenomen door de klinisch geriater. Het stoppen van medicatie, doseerwijzigingen of vervangen van een bestaand middel werden het meest uitgevoerd. Interventievoorstellen die niet werden overgenomen betroffen vooral onwil van de patiënt of diens begeleider of logistieke problemen.
Effects of a structured medication review by geriatrician and clinical pharmacologist on appropriateness of pharmacotherapy of frail elderly inpatients
Objective To study the results of a structured medication review of geriatric inpatients by both geriatrician and hospital pharmacist/clinical pharmacologist. Methods Patients who were present at the geriatric ward were eligible for a review of their medication and medical problems using a screening form. Recommendations and questions following these forms were subsequently discussed in the gerontopharmacologic meeting (‘GFO’) held every two weeks. Results In a 30 month-period 44 GFO’s were held during which 184 patients were discussed. A total of 206 recommendations were made and 115 questions were asked. Of the recommended interventions,134 (65%) were accepted by the geriatrician. To stop a medication (64/206), to change the dosage of a medication (60/206) and to switch to another medication (44/206) were the types of interventions most accounted for. Conclusion Structured medication review led to a substantial number of medication changes in geriatric inpatients. Nearly two-thirds of the recommended interventions were accepted by the geriatricians. Seventy-two recommendations (35%) were not implemented due to logistic or patient-related reasons.
Literatuur
Simonson W, Feinberg JL. Medication-related problems in the elderly. Defining the issues and identifying solutions. Drugs Aging 2005;22:559-69
Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005;22:69-82
Lau DT, Kasper JD, Potter DEB, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med. 2005;165:68-74
Leendertse AJ, Egberts ACG, Stoker LJ et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168:1890-6
de Leeuw M. Centrale rol patiënt bij medicatiereview. Pharm Weekbl 19 dec.2008 p.16-17
De Smet PAGM, Denneboom W, Kramers C, Grol R. A composite screening tool for medication reviews of outpatients. Drugs Aging 2007;24:733-60
De Gier JJ, Egberts A. Opinie:eenduidige taxonomie bevordert FPZ. Pharm Weekbl 2007;142:17
Kaboli PJ, Hoth AB, McClimon BJ, et al. Clinical pharmacists and inpatient medical care. A systematic review. Arch Intern Med 2006;166:955-64
Holland R, Lenaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomized controlled trial. BMJ, doi:10.1136/bmj.38338.674583.AE (published 24 January 2005).
Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Ger Soc 2007; 55: S373-382
Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32:113-121.
Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045-51
Vingerhoeds RW, van Marum RJ, Jansen PAF. De Beers-lijst als hulpmiddel om ernstige geneesmiddelbijwerkingen bij ouderen te voorkomen. Ned Tijdschr Geneeskd 2005;149:2099-2103.
Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370:173-84.
Holland R, Desborough J, Goodyer L et al. Does pharmacist led medication reviews help to reduce hospital admission and death in older people. Brit J Clin Pharmacol 2008;65:303-16.
Brouwers JRBJ, ten Brug E, Taxis K. Medicatiereview bij ouderen. Patient Care 2008;35(7/8):26-30.
Van Roon EN, Van Asselt DZB, Van Dijk KN, et al. Risk assessment for clinical pharmacists to detect drug related problems in geriatric patients: results of validation of an easy-to-use triage score system. Basic & Clinical Pharmacology & Toxicology, 2007; 101 (Suppl.1):191.
Van Roon EN, Flikweert S, Le Comte M, et al. Clinical relevance of drug-drug interactions: a structured assessment procedure. Drug Saf 2005;28:1131-9.
Swen JJ, Wilting I, de Goede AL et al. Pharmacogentics from bench to byte. Clin Pharmacol Therap 2008;83(5)781-88.
Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes- randomised controlled trial. Age and ageing 2006;35:586-91.
Konkaew C, Noyce PR, Ascroft DM. Hospital admissions with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 2008;42:1017-1025.
Howard RL, Avery AJ. Pharmacist-led medication reviews can reduce patient morbidity? (editorial). Age and Ageing 2006;35:555-6.
Tent M. Op consult bij het team geriater-apotheker. Unieke polikliniek polyfarmacie voor ouderen. Pharm Weekbl 2006;22:745-7.
Stuijt CM, Franssen EJF, Egberts ACG, Hudson SA. Appropriatess of prescribing among elderly patients in a Dutch residential homes:Observational study on outcomes after a pharmacist led mediation reviewDrugs Aging 2008;25:947-54.
Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care – the POLYMED randomised controlled trial. Age and Ageing 2007;36:292-297
Van der Linden CM, Kerskes MC, Bijl AM, et al. Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med 2006;166:1666-7.
Wong JD, Bajcar JM, Wong GG et al. Medication reconcilliation at hospital discharge:e valuating discrepancies. Ann Pharmacotherapy 2008;42:1373-8.
Author information
Authors and Affiliations
Additional information
Ziekenhuisapotheker, Medisch Centrum Leeuwarden, afdeling Klinische Farmacologie
Klinisch geriater, Medisch Centrum Leeuwarden, Centrum Geriatrie
Ziekenhuisapotheker io, Medisch Centrum Leeuwarden, afdeling Klinische Farmacologie
Klinisch geriater io, Medisch Centrum Leeuwarden, Centrum Geriatrie
Klinisch farmacoloog, Medisch Centrum Leeuwarden, afdeling Klinische Farmacologie
Klinisch-farmacoloog/ hoogleraar farmacotherapie, Medisch Centrum Leeuwarden, afdeling Klinische Farmacologie/Ziekenhuis de Tjongerschans afdeling: KlinischeFarmacie
About this article
Cite this article
van Dijk, K.N., van Asselt, D.Z.B., Vogel, D. et al. Interventies na een gestructureerde medicatie-analyse door klinisch geriater en ziekenhuisapotheker bij klinisch opgenomen kwetsbare oudere patiënten. GEEG 40, 35–41 (2009). https://doi.org/10.1007/BF03079563
Issue Date:
DOI: https://doi.org/10.1007/BF03079563